Intranasal drug delivery

Advanced Drug Delivery Reviews

Volumn 29, Issue 1-2, 1998, Pages 39-49

  Hussain, Anwar A ^a  

^a University of Kentucky   (United States)

Author keywords

Nasal absorption; Peptides nasal absorption; Physico chemical and biopharmaceutical properties; Transport of drugs from nasal cavity to cerebral spinal fluid

Indexed keywords

ABSORPTION; AMINO ACIDS; BODY FLUIDS; BRAIN; PHARMACOKINETICS; TRANSPORT PROPERTIES;

CEREBRAL SPINAL FLUIDS; INTRANASAL DRUG DELIVERY; PEPTIDES; PHYSICOCHEMICAL PROPERTIES;

CONTROLLED DRUG DELIVERY;

DRUG;

BIOAVAILABILITY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; HUMAN; INTRANASAL DRUG ADMINISTRATION; NOSE CAVITY; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0032484626     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(97)00060-4     Document Type: Review

References (29)

1. Physician's Desk Reference, 50th ed., Medical Economics Company Inc., NJ, 1996, p. 2017.
2. A.A. Hussain, Method of administering narcotic antagonists and analgesics and novel dosage forms containing same, US Patent 4464378, 1984.
3. Hussain A., Kimuara R., Huang C.H. Nasal absorption of testosterone in rats. J. Pharm. Sci. 73:1984;1300-1301.
4. Hussain A., Hirai S., Bawarshi R.J. Nasal absorption of natural contraceptive steroids in rats I: progesterone absorption. J. Pharm. Sci. 70:1981;466-467.
5. Bawarshi-Nassar R.A., Hussain A.A., Crooks P.A. Nasal absorption and metabolism of progesterone and 17β-estradiol in rats. Drug Metab. Dispos. 17:1989;248-254.
6. Bawarshi-Nassar R.N., Hussain A., Crooks P.A. Nasal absorption of 17α-ethinyl estradiol in the rat. J. Pharm. Pharmacol. 41:1989;214-215.
7. Physician's Desk Reference, 50th ed., Medical Economics Company Inc., NJ, 1996, p. 775.
8. Hussain A., Hirai S., Bawarshi R.J. Nasal absorption of propranolol. J. Pharm. Sci. 68:1979;1196-1199.
9. Hussain A., Hirai S., Bawarshi R.J. Nasal absorption of propranolol in rats and dogs from different dosage forms. J. Pharm. Sci. 69:1980;1411-1413.
10. Hussain A., Foster T., Hirai S., Kashikara T., Batenhorst R., Jones M.J. Nasal absorption of propranolol in humans. J. Pharm. Sci. 69:1980;1240-1244.
11. Huang C.H., Kimura R., Bawarshi-Nassar R., Hussain A. Mechanism of nasal absorption of drugs I: physical chemical parameters influencing the rate of in-situ nasal absorption of drugs in rats. J. Pharm. Sci. 74:1985;608-611.
12. Faraj J.A., Hussain A., Aramaki Y., Iseki K., Kagoshima M., Dittert L.W. Mechanism of nasal absorption of drugs III: nasal absorption of leucine enkephalin. J. Pharm. Sci. 79:1990;698-702.
13. Hussain A., Hamadi S., Kagoshima M., Iseki K., Dittert L. Does increasing the lipophilicity of peptides enhance their nasal absorption. J. Pharm. Sci. 80:1991;1180-1181.
14. Donovan M.D., Flynn G.L., Amidon G.L. Absorption of polyethylene glycols 600 through 2000: the molecular weight dependence. Pharm. Res. 7:1990;863-868.
15. Harris A.S., Nilsson I.M., Wagner Z.G., Alkner U. Intranasal administration of peptides: nasal deposition, biological response and absorption of desmopressin. J. Pharm. Sci. 75:1986;1085-1088.
16. Brittebo E.B. Metabolism of progesterone in the nasal mucosa in mice and rats. Acta Pharmacol. Toxicol. 51:1982;441-445.
17. Bogdanffy M.S., Randall H.W., Morgan K.T. Biochemical quantitation and histochemical localization of carboxyl esterase in the nasal passage of the Fischer 344 rat and B6C3F1 mouse. Toxicol. Appl. Pharmacol. 88:1987;183-194.
18. Huang G.H., Kimura R., Nassar R.B., Hussain A. Mechanism of nasal absorption of drugs II: absorption of L-tyrosine and the effect of structural modification on its absorption. J. Pharm. Sci. 74:1985;1298-1301.
19. Hussain A., Faraj J., Aramaki Y., Truelove J. Hydrolysis of leucine enkephalin in the nasal cavity of the rat: a possible factor in the low bioavailability of nasally administered peptides. Biomed. Biophys. Res. Commun. 133:1985;923-928.
20. Hirai S., Yashiki T., Mima H. Mechanisms for the enhancement of the nasal absorption of insulin by surfactants. Int. J. Pharm. 9:1981;173-176.
21. Hussain M.A., Kolval C.A., Shenvi A.B., Aungst B.J. Recovery of rat nasal mucosa from the effects of aminopeptidase inhibitors. J. Pharm. Sci. 79:1990;398-400.
22. Stratford R.E. Jr., Lee V.H.L. Aminopeptidase activity in homogenates of various absorptive mucosa in the Alpine rabbit: implication in peptide delivery. Int. J. Pharm. 30:1986;73-82.
23. Chun I.K., Chein Y.W. Transmucosal delivery of methionine enkephalin I: solution stability and kinetics of degradation in various rabbit mucosal extracts. J. Pharm. Sci. 82:1993;373-378.
24. 3H]-leucine enkephalin. J. Pharm. Sci. 79:1990;768-770.
25. H.D. Kao, Enhancement of delivery of L-Dopa by the administration of its prodrugs via the nasal route. Ph.D. Thesis, University of Kentucky, Lexington, Kentucky, 1995.
26. Kumar T.C.A., David G.F.X., Sankaranarayanan A., Puri U., Sundram K.R. Pharmacokinetics of progesterone after its administration to ovariectomized rhesus monkey by injection, infusion or nasal spraying. Proc. Natl. Acad. Sci. USA. 79:1982;4185-4189.
27. T.C.A. Kumar, G.F.X. David, K. Kumar, F. Umberkoman, M.S. Krishnamoorthy, A new approach to fertility regulation by interfering with neuroendocrine pathways. Int. Symp Simla, 1974, pp. 314-322.
28. Sakane T., Akizuki M., Yamashita S., Nadia T., Hashida M., Sezaki H. The transport of a drug to the cerebrospinal fluid directly from the nasal cavity: the relation to the lipophilicity of the drug. Chem. Pharm. Bull. 39:1991;2456-2458.
29. Sakane T., Akizuki M., Yoshida M. Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity. J. Pharm. Pharmacol. 43:1990;449-451.